Conatus Pharmaceuticals Inc. (CNAT)

[realfast95]

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.



On February 16, 2017, Charles J. Cashion tendered his resignation as Senior Vice President, Finance, Chief Financial Officer and Secretary of Conatus Pharmaceuticals Inc. (the “Company”), a position which he has held since co-founding the Company in 2005. The resignation will be effective on March 31, 2017, and he will continue to serve as Senior Vice President, Finance, Chief Financial Officer and Secretary until that date, during which time the Company expects to complete its year-end audit and file its Annual Report on Form 10-K. Mr. Cashion plans to retire and his decision to resign from the Company did not result from any disagreement with the Company concerning any matter relating to its operations, policies or practices.